nodes	percent_of_prediction	percent_of_DWPC	metapath
Tolterodine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0997	0.28	CbGbCtD
Tolterodine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0623	0.175	CbGbCtD
Tolterodine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.058	0.163	CbGbCtD
Tolterodine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0427	0.12	CbGbCtD
Tolterodine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0266	0.0747	CbGbCtD
Tolterodine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.0262	0.0734	CbGbCtD
Tolterodine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0244	0.0684	CbGbCtD
Tolterodine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0166	0.0467	CbGbCtD
Tolterodine—Urinary tract infection—Alitretinoin—peripheral nervous system neoplasm	0.00272	0.00422	CcSEcCtD
Tolterodine—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00265	0.00413	CcSEcCtD
Tolterodine—Sinusitis—Alitretinoin—peripheral nervous system neoplasm	0.00262	0.00408	CcSEcCtD
Tolterodine—Palpitations—Tretinoin—peripheral nervous system neoplasm	0.00255	0.00396	CcSEcCtD
Tolterodine—Palpitations—Isotretinoin—peripheral nervous system neoplasm	0.00255	0.00396	CcSEcCtD
Tolterodine—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00251	0.0039	CcSEcCtD
Tolterodine—Hallucination—Alitretinoin—peripheral nervous system neoplasm	0.0025	0.00388	CcSEcCtD
Tolterodine—Arthralgia—Topotecan—peripheral nervous system neoplasm	0.00247	0.00384	CcSEcCtD
Tolterodine—Chest pain—Topotecan—peripheral nervous system neoplasm	0.00247	0.00384	CcSEcCtD
Tolterodine—Oedema peripheral—Alitretinoin—peripheral nervous system neoplasm	0.00247	0.00384	CcSEcCtD
Tolterodine—Arthralgia—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00381	CcSEcCtD
Tolterodine—Arthralgia—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00381	CcSEcCtD
Tolterodine—Chest pain—Tretinoin—peripheral nervous system neoplasm	0.00245	0.00381	CcSEcCtD
Tolterodine—Chest pain—Isotretinoin—peripheral nervous system neoplasm	0.00245	0.00381	CcSEcCtD
Tolterodine—Anxiety—Tretinoin—peripheral nervous system neoplasm	0.00244	0.0038	CcSEcCtD
Tolterodine—Anxiety—Isotretinoin—peripheral nervous system neoplasm	0.00244	0.0038	CcSEcCtD
Tolterodine—Chest pain—Melphalan—peripheral nervous system neoplasm	0.00242	0.00376	CcSEcCtD
Tolterodine—Visual impairment—Alitretinoin—peripheral nervous system neoplasm	0.00242	0.00376	CcSEcCtD
Tolterodine—Hallucination—Vincristine—peripheral nervous system neoplasm	0.00241	0.00374	CcSEcCtD
Tolterodine—Dry mouth—Tretinoin—peripheral nervous system neoplasm	0.0024	0.00373	CcSEcCtD
Tolterodine—Dry mouth—Isotretinoin—peripheral nervous system neoplasm	0.0024	0.00373	CcSEcCtD
Tolterodine—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00237	0.00369	CcSEcCtD
Tolterodine—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00237	0.00369	CcSEcCtD
Tolterodine—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00237	0.00369	CcSEcCtD
Tolterodine—Infection—Topotecan—peripheral nervous system neoplasm	0.00236	0.00366	CcSEcCtD
Tolterodine—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00235	0.00366	CcSEcCtD
Tolterodine—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00235	0.00366	CcSEcCtD
Tolterodine—Oedema—Tretinoin—peripheral nervous system neoplasm	0.00235	0.00366	CcSEcCtD
Tolterodine—Oedema—Isotretinoin—peripheral nervous system neoplasm	0.00235	0.00366	CcSEcCtD
Tolterodine—Infection—Tretinoin—peripheral nervous system neoplasm	0.00234	0.00363	CcSEcCtD
Tolterodine—Infection—Isotretinoin—peripheral nervous system neoplasm	0.00234	0.00363	CcSEcCtD
Tolterodine—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00233	0.00362	CcSEcCtD
Tolterodine—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.00232	0.00361	CcSEcCtD
Tolterodine—Oedema—Melphalan—peripheral nervous system neoplasm	0.00232	0.00361	CcSEcCtD
Tolterodine—Infection—Melphalan—peripheral nervous system neoplasm	0.00231	0.00358	CcSEcCtD
Tolterodine—Tachycardia—Tretinoin—peripheral nervous system neoplasm	0.0023	0.00357	CcSEcCtD
Tolterodine—Tachycardia—Isotretinoin—peripheral nervous system neoplasm	0.0023	0.00357	CcSEcCtD
Tolterodine—Tachycardia—Melphalan—peripheral nervous system neoplasm	0.00227	0.00352	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Topotecan—peripheral nervous system neoplasm	0.00216	0.00336	CcSEcCtD
Tolterodine—Flatulence—Alitretinoin—peripheral nervous system neoplasm	0.00215	0.00334	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Tretinoin—peripheral nervous system neoplasm	0.00214	0.00333	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Isotretinoin—peripheral nervous system neoplasm	0.00214	0.00333	CcSEcCtD
Tolterodine—Influenza like illness—Epirubicin—peripheral nervous system neoplasm	0.00212	0.0033	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Melphalan—peripheral nervous system neoplasm	0.00211	0.00329	CcSEcCtD
Tolterodine—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00209	0.00325	CcSEcCtD
Tolterodine—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00209	0.00325	CcSEcCtD
Tolterodine—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00209	0.00324	CcSEcCtD
Tolterodine—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.00207	0.00322	CcSEcCtD
Tolterodine—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.00207	0.00322	CcSEcCtD
Tolterodine—Visual impairment—Cisplatin—peripheral nervous system neoplasm	0.00206	0.0032	CcSEcCtD
Tolterodine—Fatigue—Topotecan—peripheral nervous system neoplasm	0.00204	0.00318	CcSEcCtD
Tolterodine—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00204	0.00318	CcSEcCtD
Tolterodine—Fatigue—Isotretinoin—peripheral nervous system neoplasm	0.00203	0.00315	CcSEcCtD
Tolterodine—Fatigue—Tretinoin—peripheral nervous system neoplasm	0.00203	0.00315	CcSEcCtD
Tolterodine—Pain—Topotecan—peripheral nervous system neoplasm	0.00203	0.00315	CcSEcCtD
Tolterodine—Constipation—Topotecan—peripheral nervous system neoplasm	0.00203	0.00315	CcSEcCtD
Tolterodine—Dry eye—Epirubicin—peripheral nervous system neoplasm	0.00202	0.00314	CcSEcCtD
Tolterodine—Pain—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00313	CcSEcCtD
Tolterodine—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00313	CcSEcCtD
Tolterodine—Constipation—Tretinoin—peripheral nervous system neoplasm	0.00201	0.00313	CcSEcCtD
Tolterodine—Constipation—Isotretinoin—peripheral nervous system neoplasm	0.00201	0.00313	CcSEcCtD
Tolterodine—Fatigue—Melphalan—peripheral nervous system neoplasm	0.002	0.00311	CcSEcCtD
Tolterodine—Pain—Melphalan—peripheral nervous system neoplasm	0.00199	0.00309	CcSEcCtD
Tolterodine—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00198	0.00308	CcSEcCtD
Tolterodine—Influenza like illness—Doxorubicin—peripheral nervous system neoplasm	0.00196	0.00305	CcSEcCtD
Tolterodine—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00195	0.00304	CcSEcCtD
Tolterodine—Gastrointestinal pain—Topotecan—peripheral nervous system neoplasm	0.00194	0.00301	CcSEcCtD
Tolterodine—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00194	0.00301	CcSEcCtD
Tolterodine—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00194	0.00301	CcSEcCtD
Tolterodine—Palpitations—Alitretinoin—peripheral nervous system neoplasm	0.00193	0.003	CcSEcCtD
Tolterodine—Gastrointestinal pain—Isotretinoin—peripheral nervous system neoplasm	0.00192	0.00299	CcSEcCtD
Tolterodine—Gastrointestinal pain—Tretinoin—peripheral nervous system neoplasm	0.00192	0.00299	CcSEcCtD
Tolterodine—Oedema—Dactinomycin—peripheral nervous system neoplasm	0.00192	0.00299	CcSEcCtD
Tolterodine—Infection—Dactinomycin—peripheral nervous system neoplasm	0.00191	0.00297	CcSEcCtD
Tolterodine—Abnormal vision—Epirubicin—peripheral nervous system neoplasm	0.00191	0.00296	CcSEcCtD
Tolterodine—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00189	0.00294	CcSEcCtD
Tolterodine—Abdominal pain—Topotecan—peripheral nervous system neoplasm	0.00187	0.00291	CcSEcCtD
Tolterodine—Dry eye—Doxorubicin—peripheral nervous system neoplasm	0.00187	0.0029	CcSEcCtD
Tolterodine—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00289	CcSEcCtD
Tolterodine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.00186	0.00289	CcSEcCtD
Tolterodine—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.00186	0.00289	CcSEcCtD
Tolterodine—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.00186	0.00289	CcSEcCtD
Tolterodine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.00185	0.00288	CcSEcCtD
Tolterodine—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.00183	0.00285	CcSEcCtD
Tolterodine—Dry mouth—Alitretinoin—peripheral nervous system neoplasm	0.00182	0.00283	CcSEcCtD
Tolterodine—Flushing—Etoposide—peripheral nervous system neoplasm	0.00182	0.00282	CcSEcCtD
Tolterodine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.0018	0.00279	CcSEcCtD
Tolterodine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00277	CcSEcCtD
Tolterodine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.00178	0.00277	CcSEcCtD
Tolterodine—Infection—Alitretinoin—peripheral nervous system neoplasm	0.00177	0.00275	CcSEcCtD
Tolterodine—Abnormal vision—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00274	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.00175	0.00272	CcSEcCtD
Tolterodine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00175	0.00272	CcSEcCtD
Tolterodine—Tachycardia—Alitretinoin—peripheral nervous system neoplasm	0.00174	0.0027	CcSEcCtD
Tolterodine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00173	0.00269	CcSEcCtD
Tolterodine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00173	0.00269	CcSEcCtD
Tolterodine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00172	0.00267	CcSEcCtD
Tolterodine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00172	0.00267	CcSEcCtD
Tolterodine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00171	0.00266	CcSEcCtD
Tolterodine—Infection—Vincristine—peripheral nervous system neoplasm	0.00171	0.00265	CcSEcCtD
Tolterodine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.0017	0.00264	CcSEcCtD
Tolterodine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00169	0.00262	CcSEcCtD
Tolterodine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00169	0.00262	CcSEcCtD
Tolterodine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.00167	0.00259	CcSEcCtD
Tolterodine—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.00166	0.00258	CcSEcCtD
Tolterodine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00164	0.00256	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.00164	0.00255	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00162	0.00252	CcSEcCtD
Tolterodine—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00162	0.00252	CcSEcCtD
Tolterodine—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.00161	0.0025	CcSEcCtD
Tolterodine—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.00161	0.0025	CcSEcCtD
Tolterodine—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.00159	0.00247	CcSEcCtD
Tolterodine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00158	0.00246	CcSEcCtD
Tolterodine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00158	0.00246	CcSEcCtD
Tolterodine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.00158	0.00245	CcSEcCtD
Tolterodine—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.00157	0.00244	CcSEcCtD
Tolterodine—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00157	0.00244	CcSEcCtD
Tolterodine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00157	0.00244	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.00156	0.00243	CcSEcCtD
Tolterodine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00156	0.00242	CcSEcCtD
Tolterodine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00156	0.00242	CcSEcCtD
Tolterodine—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.00154	0.00239	CcSEcCtD
Tolterodine—Vertigo—Etoposide—peripheral nervous system neoplasm	0.00153	0.00238	CcSEcCtD
Tolterodine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00237	CcSEcCtD
Tolterodine—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.00152	0.00237	CcSEcCtD
Tolterodine—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.00152	0.00236	CcSEcCtD
Tolterodine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00236	CcSEcCtD
Tolterodine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.00152	0.00236	CcSEcCtD
Tolterodine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.00152	0.00236	CcSEcCtD
Tolterodine—Infection—Cisplatin—peripheral nervous system neoplasm	0.00151	0.00235	CcSEcCtD
Tolterodine—Headache—Topotecan—peripheral nervous system neoplasm	0.00149	0.00231	CcSEcCtD
Tolterodine—Tachycardia—Cisplatin—peripheral nervous system neoplasm	0.00148	0.0023	CcSEcCtD
Tolterodine—Fatigue—Vincristine—peripheral nervous system neoplasm	0.00148	0.0023	CcSEcCtD
Tolterodine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00147	0.00229	CcSEcCtD
Tolterodine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00147	0.00229	CcSEcCtD
Tolterodine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00147	0.00228	CcSEcCtD
Tolterodine—Pain—Vincristine—peripheral nervous system neoplasm	0.00147	0.00228	CcSEcCtD
Tolterodine—Constipation—Vincristine—peripheral nervous system neoplasm	0.00147	0.00228	CcSEcCtD
Tolterodine—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.00146	0.00227	CcSEcCtD
Tolterodine—Dry skin—Epirubicin—peripheral nervous system neoplasm	0.00145	0.00226	CcSEcCtD
Tolterodine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.00145	0.00226	CcSEcCtD
Tolterodine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00142	0.0022	CcSEcCtD
Tolterodine—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.00141	0.00219	CcSEcCtD
Tolterodine—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.0014	0.00218	CcSEcCtD
Tolterodine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.0014	0.00218	CcSEcCtD
Tolterodine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00139	0.00216	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00138	0.00215	CcSEcCtD
Tolterodine—Infection—Etoposide—peripheral nervous system neoplasm	0.00138	0.00215	CcSEcCtD
Tolterodine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.00138	0.00214	CcSEcCtD
Tolterodine—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.00136	0.00211	CcSEcCtD
Tolterodine—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.00136	0.00211	CcSEcCtD
Tolterodine—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00135	0.00209	CcSEcCtD
Tolterodine—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.00132	0.00205	CcSEcCtD
Tolterodine—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.00132	0.00204	CcSEcCtD
Tolterodine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00131	0.00204	CcSEcCtD
Tolterodine—Pain—Cisplatin—peripheral nervous system neoplasm	0.0013	0.00202	CcSEcCtD
Tolterodine—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.00128	0.00199	CcSEcCtD
Tolterodine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.00128	0.00199	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00127	0.00198	CcSEcCtD
Tolterodine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00127	0.00197	CcSEcCtD
Tolterodine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00125	0.00195	CcSEcCtD
Tolterodine—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00194	CcSEcCtD
Tolterodine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00124	0.00192	CcSEcCtD
Tolterodine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.00123	0.00192	CcSEcCtD
Tolterodine—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.00122	0.0019	CcSEcCtD
Tolterodine—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.00122	0.0019	CcSEcCtD
Tolterodine—Fatigue—Etoposide—peripheral nervous system neoplasm	0.0012	0.00186	CcSEcCtD
Tolterodine—Constipation—Etoposide—peripheral nervous system neoplasm	0.00119	0.00185	CcSEcCtD
Tolterodine—Pain—Etoposide—peripheral nervous system neoplasm	0.00119	0.00185	CcSEcCtD
Tolterodine—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00185	CcSEcCtD
Tolterodine—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.00119	0.00184	CcSEcCtD
Tolterodine—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.00118	0.00183	CcSEcCtD
Tolterodine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00118	0.00183	CcSEcCtD
Tolterodine—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00118	0.00183	CcSEcCtD
Tolterodine—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.0018	CcSEcCtD
Tolterodine—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.00115	0.00178	CcSEcCtD
Tolterodine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00115	0.00178	CcSEcCtD
Tolterodine—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00114	0.00177	CcSEcCtD
Tolterodine—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00114	0.00177	CcSEcCtD
Tolterodine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.00112	0.00174	CcSEcCtD
Tolterodine—Headache—Alitretinoin—peripheral nervous system neoplasm	0.00112	0.00174	CcSEcCtD
Tolterodine—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.0011	0.00171	CcSEcCtD
Tolterodine—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.00171	CcSEcCtD
Tolterodine—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.00109	0.00169	CcSEcCtD
Tolterodine—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.00108	0.00168	CcSEcCtD
Tolterodine—Headache—Vincristine—peripheral nervous system neoplasm	0.00108	0.00167	CcSEcCtD
Tolterodine—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.00106	0.00165	CcSEcCtD
Tolterodine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.00106	0.00164	CcSEcCtD
Tolterodine—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.00104	0.00162	CcSEcCtD
Tolterodine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00103	0.00159	CcSEcCtD
Tolterodine—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00102	0.00158	CcSEcCtD
Tolterodine—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.001	0.00156	CcSEcCtD
Tolterodine—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000998	0.00155	CcSEcCtD
Tolterodine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000979	0.00152	CcSEcCtD
Tolterodine—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000952	0.00148	CcSEcCtD
Tolterodine—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000943	0.00147	CcSEcCtD
Tolterodine—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000942	0.00146	CcSEcCtD
Tolterodine—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00092	0.00143	CcSEcCtD
Tolterodine—Headache—Etoposide—peripheral nervous system neoplasm	0.000872	0.00135	CcSEcCtD
Tolterodine—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000871	0.00135	CcSEcCtD
Tolterodine—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000859	0.00133	CcSEcCtD
Tolterodine—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000844	0.00131	CcSEcCtD
Tolterodine—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000814	0.00126	CcSEcCtD
Tolterodine—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000814	0.00126	CcSEcCtD
Tolterodine—Anxiety—Epirubicin—peripheral nervous system neoplasm	0.000811	0.00126	CcSEcCtD
Tolterodine—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000796	0.00124	CcSEcCtD
Tolterodine—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000794	0.00123	CcSEcCtD
Tolterodine—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000786	0.00122	CcSEcCtD
Tolterodine—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000781	0.00121	CcSEcCtD
Tolterodine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00121	CcSEcCtD
Tolterodine—Oedema—Epirubicin—peripheral nervous system neoplasm	0.00078	0.00121	CcSEcCtD
Tolterodine—Infection—Epirubicin—peripheral nervous system neoplasm	0.000775	0.0012	CcSEcCtD
Tolterodine—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000761	0.00118	CcSEcCtD
Tolterodine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.00117	CcSEcCtD
Tolterodine—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000753	0.00117	CcSEcCtD
Tolterodine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	0.00075	0.00117	CcSEcCtD
Tolterodine—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000736	0.00114	CcSEcCtD
Tolterodine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.000728	0.00113	CcSEcCtD
Tolterodine—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.00112	CcSEcCtD
Tolterodine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.000722	0.00112	CcSEcCtD
Tolterodine—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000717	0.00111	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000711	0.0011	CcSEcCtD
Tolterodine—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000704	0.00109	CcSEcCtD
Tolterodine—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000693	0.00108	CcSEcCtD
Tolterodine—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000686	0.00107	CcSEcCtD
Tolterodine—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000672	0.00105	CcSEcCtD
Tolterodine—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000667	0.00104	CcSEcCtD
Tolterodine—Pain—Epirubicin—peripheral nervous system neoplasm	0.000667	0.00104	CcSEcCtD
Tolterodine—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000657	0.00102	CcSEcCtD
Tolterodine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000643	0.000999	CcSEcCtD
Tolterodine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000641	0.000997	CcSEcCtD
Tolterodine—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000638	0.000991	CcSEcCtD
Tolterodine—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000635	0.000987	CcSEcCtD
Tolterodine—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000622	0.000967	CcSEcCtD
Tolterodine—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000959	CcSEcCtD
Tolterodine—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000959	CcSEcCtD
Tolterodine—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000616	0.000958	CcSEcCtD
Tolterodine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000595	0.000924	CcSEcCtD
Tolterodine—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.00059	0.000917	CcSEcCtD
Tolterodine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000575	0.000893	CcSEcCtD
Tolterodine—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00057	0.000887	CcSEcCtD
Tolterodine—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.00056	0.00087	CcSEcCtD
Tolterodine—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000829	CcSEcCtD
Tolterodine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000532	0.000826	CcSEcCtD
Tolterodine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000518	0.000805	CcSEcCtD
Tolterodine—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000516	0.000802	CcSEcCtD
Tolterodine—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000767	CcSEcCtD
Tolterodine—Headache—Epirubicin—peripheral nervous system neoplasm	0.000489	0.000759	CcSEcCtD
Tolterodine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000477	0.000742	CcSEcCtD
Tolterodine—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000452	0.000703	CcSEcCtD
Tolterodine—Fesoterodine—ABCB1—peripheral nervous system neoplasm	0.000181	1	CrCbGaD
